1137 related articles for article (PubMed ID: 28190475)
1. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
[TBL] [Abstract][Full Text] [Related]
2. Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice.
Duan X; Meng Q; Wang C; Liu Z; Sun H; Huo X; Sun P; Ma X; Peng J; Liu K
J Gastroenterol Hepatol; 2018 Feb; 33(2):533-542. PubMed ID: 28699662
[TBL] [Abstract][Full Text] [Related]
3. Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation.
Meng Q; Duan XP; Wang CY; Liu ZH; Sun PY; Huo XK; Sun HJ; Peng JY; Liu KX
Acta Pharmacol Sin; 2017 Jan; 38(1):69-79. PubMed ID: 27773935
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of glycyrrhizic acid from edible botanical glycyrrhiza glabra against non-alcoholic steatohepatitis in mice.
Wang C; Duan X; Sun X; Liu Z; Sun P; Yang X; Sun H; Liu K; Meng Q
Food Funct; 2016 Sep; 7(9):3716-23. PubMed ID: 27487733
[TBL] [Abstract][Full Text] [Related]
5. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
Zhang S; Wang J; Liu Q; Harnish DC
J Hepatol; 2009 Aug; 51(2):380-8. PubMed ID: 19501927
[TBL] [Abstract][Full Text] [Related]
7. Danhe granule ameliorates nonalcoholic steatohepatitis and fibrosis in rats by inhibiting ceramide de novo synthesis related to CerS6 and CerK.
Zhu M; Jia Z; Yan X; Liu L; Fang C; Feng M; Dai Y; Zhang Y; Wu H; Huang B; Li Y; Liu J; Xiao H
J Ethnopharmacol; 2022 Sep; 295():115427. PubMed ID: 35654350
[TBL] [Abstract][Full Text] [Related]
8. The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism.
Zhao Q; Wei M; Zhang S; Huang Z; Lu B; Ji L
Phytomedicine; 2020 Oct; 77():153270. PubMed ID: 32702591
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
11. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
Liu M; Zhang G; Wu S; Song M; Wang J; Cai W; Mi S; Liu C
J Ethnopharmacol; 2020 Jun; 255():112776. PubMed ID: 32205261
[TBL] [Abstract][Full Text] [Related]
12. Effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice.
Chen T; Zhong FJ; Hong YM; Su WJ; Zhuang LL; Qiu LX
Chin J Nat Med; 2014 Mar; 12(3):194-8. PubMed ID: 24702805
[TBL] [Abstract][Full Text] [Related]
13. Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling.
Gu M; Zhang S; Zhao Y; Huang J; Wang Y; Li Y; Fan S; Yang L; Ji G; Tong Q; Huang C
Pharmacol Res; 2017 Jul; 121():22-32. PubMed ID: 28428116
[TBL] [Abstract][Full Text] [Related]
14. Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK/SREBP1 signaling pathway.
Zhang L; Li HX; Pan WS; Khan FU; Qian C; Qi-Li FR; Xu X
Biomed Pharmacother; 2019 Feb; 110():571-581. PubMed ID: 30537674
[TBL] [Abstract][Full Text] [Related]
15. Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice.
Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K
Int Immunopharmacol; 2019 Oct; 75():105797. PubMed ID: 31421545
[TBL] [Abstract][Full Text] [Related]
16. Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor.
Dong R; Yang X; Wang C; Liu K; Liu Z; Ma X; Sun H; Huo X; Fu T; Meng Q
Phytomedicine; 2019 Feb; 53():134-142. PubMed ID: 30668392
[TBL] [Abstract][Full Text] [Related]
17. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.
Wu W; Liu X; Peng X; Xue R; Ji L; Shen X; Chen S; Gu J; Zhang S
Biochem Biophys Res Commun; 2014 May; 448(1):50-5. PubMed ID: 24747563
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of isochlorogenic acid B on liver fibrosis in non-alcoholic steatohepatitis of mice.
Liu X; Huang K; Niu Z; Mei D; Zhang B
Basic Clin Pharmacol Toxicol; 2019 Feb; 124(2):144-153. PubMed ID: 30180301
[TBL] [Abstract][Full Text] [Related]
19. The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats.
Lin Z; Wu ZF; Jiang CH; Zhang QW; Ouyang S; Che CT; Zhang J; Yin ZQ
Phytomedicine; 2016 Nov; 23(12):1475-1483. PubMed ID: 27765368
[TBL] [Abstract][Full Text] [Related]
20. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
